Rymti 50 mg Injection 1 ml is an immunosuppressant medicine that helps reduce signs and symptoms of autoimmune disorders. It is primarily used in the treatment of rheumatoid arthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, and plaque psoriasis. Rymti 50 mg Injection 1 ml is generally used alone or in combination with methotrexate medicine.

Rymti 50 mg Injection 1 ml consists of Etanercept, which belongs to the TNF (Tumor necrosis factor) inhibitor class of drugs. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain caused due to various autoimmune diseases.

Rymti 50 mg Injection 1 ml may cause certain side effects such as tingling or numbness, dizziness, shortness of breath, bleeding, pale skin, bruising, vision problem, redness on the skin and arms, and injection site reactions. Most of these side effects do not require medical attention or resolve over time. However, if these side effects persist for longer, please consult your doctor on priority. Rymti 50 mg Injection 1 ml is a parenteral medicine. It will be administered by a trained healthcare doctor. Hence, do not self-administer. Your physician will decide the dose and duration of the medicine based on the type and severity of the condition.

Rymti 50 mg Injection 1 ml should be avoided if allergic to it or any other components present.  Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, alcoholic hepatitis, Hepatitis B Virus infection, heart failure, liver, heart, or kidney diseases, or a weak immune system, as it can worsen your health condition. Rymti 50 mg Injection 1 ml may cause dizziness, so drive only if you are alert and focused. Rymti 50 mg Injection 1 ml should not be given to children under two years of age as safety has not been established. Avoid consuming alcohol along with Rymti 50 mg Injection 1 ml as it could lead to increased dizziness and risk of liver damage. Rymti 50 mg Injection 1 ml is not recommended for use in pregnant and nursing mothers as it can cause serious adverse effects on the baby.

Rymti 50 mg Injection 1 ml consists of Etanercept, which belongs to TNF (Tumor necrosis factor) inhibitor class of drugs. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce pain, redness, and inflammation (swelling) in patients with rheumatoid arthritis, ankylosing spondylitis, and other autoimmune disorders.

Rymti 50 mg Injection 1 ml should be avoided if allergic to it or any other components present.  Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, alcoholic hepatitis, Hepatitis B Virus infection, heart failure, liver, heart or kidney diseases, weak immune system, multiple sclerosis (nerve and muscle disease), and diabetes as it can worsen your health condition. Do not take live vaccines while being treated with Rymti 50 mg Injection 1 ml to prevent any serious consequences. Rymti 50 mg Injection 1 ml may cause dizziness and drowsiness, so drive only if you are alert and focused. Avoid consuming alcohol along with Rymti 50 mg Injection 1 ml as it could lead to increased dizziness and risk of stomach bleeding/ulcers. Rymti 50 mg Injection 1 ml is not recommended for use in children below two years of age as safety and efficacy is not established. This medicine is not recommended for patients suffering from sepsis as it can worsen the condition.

• It is advised to closely monitor the patient for infections like active tuberculosis during and after the treatment though the patient gets a negative tuberculin test.
• It is essential to inform your doctor if you have any active viral, bacterial, and fungal infections before starting Rymti 50 mg Injection 1 ml.